Amy Shapiro
Pediatric Hematology-Oncology · Indianapolis, INNPI 1942380274
Payments from drug & device makers
Across 1,774 payments — averaging $1305.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$451K
- Genentech, Inc.$405K
- Servier Bioinnovation$383K
- Kedrion S.p.a.$252K
- Pfizer$204K
- Agios Pharmaceuticals, Inc.$132K
- plus $488K from 17 others
Across 56 payments — averaging $805.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$22K
- Bioverativ Therapeutics Inc.$11K
- Pfizer$8K
- Sanofi$4K
- Sanofi-aventis U.S. LLC$245
What the payments were for
- Consulting fees$201,00170%
- Speaking & faculty fees$60,79721%
- Travel & lodging$23,9228%
- Food & beverage$1,5031%
- Education$1860%
- Gifts$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 1,311 | $451,108 |
| Genentech, Inc. | 62 | $405,485 |
| Servier Bioinnovation | 4 | $383,409 |
| Kedrion S.p.a. | 13 | $251,881 |
| Pfizer | 33 | $204,277 |
| Agios Pharmaceuticals, Inc. | 36 | $132,103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 86 | $95,000 |
| Bioverativ Therapeutics Inc. | 57 | $77,959 |
| Novo Nordisk | 34 | $65,155 |
| Novo Nordisk Health Care AG | 22 | $57,272 |
| Shire North American Group Inc | 33 | $38,608 |
| Genentech USA, Inc. | 23 | $36,474 |
| Biomarin Pharmaceutical Inc. | 17 | $33,504 |
| Sanofi | 11 | $29,619 |
| Regeneron | 3 | $15,236 |
| F. Hoffmann-la Roche AG | 10 | $13,414 |
| Sanofi US Services Inc. | 5 | $9,993 |
| Novartis | 1 | $7,246 |
| CSL Behring | 5 | $3,534 |
| HEMA Biologics, LLC | 5 | $3,012 |
| Bio Products Laboratory USA, Inc. | 1 | $2,250 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,316,565 in reported general payments places this provider in the 95th percentile of 59 pediatric hematology-oncology providers in Indiana.
See all pediatric hematology-oncology providers in Indiana →
Other pediatric hematology-oncology in Indianapolis
- Terry VikIndianapolis$1.8M
- Sanjay AhujaIndianapolis$1.4M
- Brian WeissIndianapolis$978K
- Sandeep BatraIndianapolis$845K
- Scott CovenIndianapolis$567K
- Bassem RazzoukIndianapolis$477K
- Melissa BearIndianapolis$378K
- James CroopIndianapolis$317K
- Kathleen OverholtIndianapolis$297K
- Marissa JustIndianapolis$197K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.